An examination of the relative expression levels of FADD, caspase-8, RIP1, and RIP3 in the lenalidomide- and bortezomib-resistant myeloma cells and their parental myeloma cells might help identify a possible programmed cell death pathway to overcome drug resistance. Here, CASP8 is linked to plasma cell myeloma.